Both the PSMC6 and MAPK8 genes were upregulated in melanosis coli patients [40], and CRISPR Genome-Wide Screening demonstrated that the PSMC6 subunit is an important and sensitive target for bortezomib in multiple myeloma cells [41]. Here, PSMC6 is linked to plasma cell myeloma.